Acorah Software Products - Accounts Production19.2.350truetrue31 May 20251 June 2024falsetrueNo description of principal activity1 June 202531 May 202631 May 2026NI687851Mr Martin McNallyiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pureNI6878512025-05-31NI6878512026-05-31NI6878512025-06-012026-05-31NI687851frs-bus:PrivateLimitedCompanyLtd2025-06-012026-05-31NI687851frs-bus:FilletedAccounts2025-06-012026-05-31NI687851frs-bus:Micro-entities2025-06-012026-05-31NI687851frs-bus:EntityHasNeverTraded2025-06-012026-05-31NI687851frs-bus:AuditExempt-NoAccountantsReport2025-06-012026-05-31NI687851frs-bus:Director12025-06-012026-05-31NI6878512024-05-31NI6878512025-05-31NI6878512024-06-012025-05-31
Registered number: NI687851
Pharmscription Ltd
Dormant Financial Statements
For The Year Ended 31 May 2026
Flynn & Company Accountants Limited
Pharmscription Ltd
Balance Sheet
As At 31 May 2026
Balance Sheet
Registered number: NI687851
2026
2025
£
£
Current assets
100
100
NET CURRENT ASSETS
100
100
TOTAL ASSETS LESS CURRENT LIABILITIES
100
100
NET ASSETS
100
100
CAPITAL AND RESERVES
100
100
Notes
1.General Information
Pharmscription Ltd is a private company, limited by shares, incorporated in Northern Ireland, registered number NI687851. The registered office is 28 Carleton Street, Portadown, Craigavon, BT62 3EP.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2025: NIL)
--
For the year ending 31 May 2026 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.